Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Glaucoma. 2017 Aug;26(8):687–693. doi: 10.1097/IJG.0000000000000720

Table 1. Mean (SD) percentage use of antifibrotics during primary trabeculectomy and phacoemulsification/trabeculectomy.

1996 2002 2008 2016 p-value
Primary trabeculectomy
 MMC 45 (41) 68 (37) 84 (26) 97 (12) <0.001
 5-FU (IO + PO) 29 (39) 39 (37) 5 (16) 0.8 (6) <0.001
 5-FU (IO only) * 23 (33) 3 (10) 0.7 (7) <0.001
 No antifibrotic * * 7 (19) 0.9 (7) <0.001
Phacoemulsification/trabeculectomy
 MMC 65 (43) 83 (33) 90 (24) 99 (8) <0.001
 5-FU (IO + PO) 18 (34) 15 (35) 2 (10) 0.3 (2) <0.001
 5-FU (IO only) * 6 (20) 1 (6) < 0.1 0.009
 No antifibrotic * * 6 (21) 1 (8) 0.001

5-FU = 5-fluorouracil; IO = intraoperative; MMC = mitomycin C; PO = postoperative; SD = standard deviation.

Data are presented as average percentage (standard deviation of percentage). Percentage in each category may not sum to 100% because of rounding and free-texted responses in the “Other” category for which specific percentage use was not reported.

*

Answer choice not presented in survey.

One way analysis of variance (ANOVA) was used to assess the statistical significance of the differences among three means.

Student t-test was used to assess the statistical significance of the difference between two means.